Skip to content
Trial Eligibility
Menu

Hemoglobin Testing in Pregnant Patients

NCT05977686

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The project is a prospective observational study aimed to assess and to validate the use of point-of-care hemoglobin testing in pregnancy. Point-of-care hemoglobin testing has the potential to (1) increase access to hemoglobin monitoring in pregnancy in low resource settings, (2) increase availability of hemoglobin monitoring in anemic patients, and (3) provide immediate results for real-time patient counseling and intervention. However, to date, point-of-care hemoglobin testing devices have not yet been studied for use in an ambulatory obstetric population.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Post Partum Hemorrhage
  • Anemia of Pregnancy

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
18 to 50 years
Sex
Female
Healthy volunteers
Accepted
Sponsor
Inova Health Care Services
Last updated on ClinicalTrials.gov
October 15, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Virginia · 1

  • Inova Health System · Falls Church, VA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.